Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/wehi mice

Journal of Clinical Investigation

Volumn 87, Issue 2, 1991, Pages 739-742

  Campbell, Iain L ^a,b   Kay, Thomas W H ^a   Oxbrow, Leonie ^a   Harrison, Leonard C ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Anti cytokine therapy; Beta cell; Pancreatic islet

Indexed keywords

CYCLOPHOSPHAMIDE; GAMMA INTERFERON; INTERLEUKIN 6;

ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; CYCLOPHOSPHAMIDE; DIABETES MELLITUS, INSULIN-DEPENDENT; FEMALE; INTERFERON TYPE II; INTERLEUKIN-6; ISLETS OF LANGERHANS; MICE; SUPPORT, NON-U.S. GOV'T;

EID: 0025981388     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI115055     Document Type: Article

References (34)

1. Eisenbarth, G. S. 1986. Type 1 diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 314:1360-1368.
2. Campbell, I. L. and L. C. Harrison. 1990. Molecular pathology of type-1 diabetes. Mol. Biol. Med. 7:299-309.
3. Marliss, E. B., A. F. Nakhooda, and P. Poussier. 1983. Clinical forms and natural history of the diabetic syndrome and insulin and glucagon secretion in the BB rat. Metabolism. 32(Suppl.):11-16.
4. Leiter, E. H., M. Prochazka, and D. L. Coleman. 1987. The nonobese diabetic (NOD) mouse. Am. J. Pathol. 128:380-393.
5. Gepts, W., and P. M. Lecompte. 1981. The pancreatic islets in diabetes. Am. J. Med. 70:105-115.
6. Bottazzo, G. F., B. M. Dean, J. M. McNally, E. H. Mackay, P. G. F. Swift, and D. R. Gamble. 1985. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med. 31:353-360.
7. Foulis, A. K., C. N. Liddle, M. A. Farquharson, and J. A. Richmond. 1986. The histopathology of the pancreas in type I (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia. 29:267-274.
8. Bach, J. F. 1988. Mechanisms of autoimmunity in insulin-dependent diabetes mellitus. Clin. Exp. Immunol. 72:1-8.
9. Lampeter, E. F., A. Signore, E. A. M. Gale, and P. Pozzilli. 1989. Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus. Diabelologia. 32:703-708.
10. Mandrup-Poulsen, T., S. Helqvist, and J. Molvig. 1989. Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin dependent diabetes mellitus. Autoimmunity. 4:191-218.
11. Campbell, I. L., G. H. W. Wong, J. W. Schrader, and L. C. Harrison. 1985. Interferon-γ enhances the expression of the major histocompatibility class I antigens on mouse pancreatic beta cells. Diabetes. 34:1205-1209.
12. Campbell, I. L., K. Bisilj, P. G. Colman, B. Tuch, and L. C. Harrison. 1986. Interferon-γ induces the expression of HLA-A,B,C but not HLA-DR antigens on human pancreatic beta cells. J. Clin. Endocrinol. Metab. 62:1101-1109.
13. Pujol-Borrell, R., I. Todd, M. Doslin, G. F. Bottazzo, R. Sutton, D. Gray, G. R. Adolf, and M. Feldmann. 1987. HLA class II induction in tumour islet cells by interferon-γ plus tumour necrosis factor or lymphotoxin. Nature (Lond.). 326:304-306.
14. Campbell, I. L., L. Oxbrow, J. West, and L. C. Harrison. 1988. Regulation of MHC protein expression in pancreatic beta cells by interferon-γ and tumour necrosis factor-α Mol. Endocrinol. 2:101-107.
15. Campbell, I. L., A Cutri, D. Wilkinson, A. W. Boyd, and L. C. Harrison. 1989. Intercellular adhesion molecule-1 induced on endocrine islet cells by cytokines but not by reovirus infection. Proc. Natl. Acad. Sci. USA. 86:4282-4286.
16. Bendtzen, K., T. Mandrup-Poulsen, J. Nerup, J. H. Nielsen, C. A. Dinarello, and M. Svenson. 1986. Cytotoxicity of human pI7 imerleukin-1 for pancreatic islets of Langerhans. Science (Wash. DC). 232:1545-1547.
17. Pukel, C., H. Baquerizo, and A. Rabinovitch. 1988. Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-γ, tumour necrosis factor, lymphotoxin and interleukin-1. Diabetes. 37:133-136.
18. Campbell, I. L., A. Iscaro, and L. C. Harrison. 1988. IFN-γ and tumor necrosis factor-α. Cytotoxicity to murine islets of Langerhans. J. Immunol. 141:2325-2329.
19. Campbell, I. L., A. Cutri, A. Wilson, and L. C. Harrison. 1989. Evidence for interleukin-6 production by and effects on the pancreatic beta cells. J. Immunol. 143:1188-1191.
20. Le, J., and J. Vilcek. 1989. Interleukin-6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab. Invest. 61:588-602.
21. Charlton, B., A. Bacelj, and T. E. Mandel. 1988. Administration of silica particles or anti-Ly2 antibody prevents 3-cell destruction in NOD mice given cyclophosphamide. Diabetes. 37:930-935.
22. Baxter, A. G., M. A. Adams, and T. E. Mandel. 1989. Comparison of high and low diabetes incidence NOD mouse strains. Diabetes 38:1296-1300.
23. Leo, D., M. Foo, D. H. Sachs, L. E. Samelson, and J. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA. 84:1374-1378.
24. Nordan, R. P., and M. Potter. 1986. A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science (Wash. DC). 233:566-569.
25. Tada, H., O. Shiho, K.-I. Kuroshima, M. Koyama, and K. Tsukumoto. 1986. An improved colorimetric assay for interleukin 2. J. Immunol. Methods, 93:157-162.
26. Charlton, B., A. Bacelj, R. M. Slattery, and T. E. Mandel. 1989. Cyclophosphamide-induced diabetes in NOD/Wehi mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes. 38:441-447.
27. Kay, T. W. H., I. L. Campbell, and L. C. Harrison. 1989. Characterization of pancreatic T lymphocytes associated with beta cell destruction in the nonobese diabetic (NOD) mouse. J. Autoimmunity 3:73. (Abstr.)
28. Le, J., and J. Vilcek. 1989. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab. Invest. 61:588-602.
29. Hirano, T., T. Matsuda, M. Turner, N. Miyasaka, G. Buchan, B. Tang, K. Sato, M. Shimizu, R. Muini, M. Feldmann, and T. Kishimoto. 1988. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur. J. Imnnmol. 18:1797-1802.
30. Waage, A., C. Kaufmann, T. Espevik, and G. Husby. 1989. Interleukin-6 in synovial fluid from patients with arthritis, Clin. Immunol. Immunopathol. 50:394-400.
31. Campbell, I. L., and L. C. Harrison. 1990. A new view of the beta cell as an antigen presenting cell and immunogenic target. J. Autoimmunity. 3(Suppl.):53-62.
32. Takai, Y., G. C. Wong, S. C. Clark, S. J. Burakoff, and S. H. Herrmann. 1988. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J. Immunol. 140:508-512.
33. Harrison, L. C., and I. L. Campbell. 1988. Cytokines: an expanding network of immunoinflammatory hormones. Mol. Endocrinol. 2:1151-1156.
34. Jacob, C. O., S. Aiso, S. A. Michie, H. O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-α and interleukin 1. Proc. Natl. Acad. Sci. USA. 87:968-972.